Analyzing Mayo Clinic’s growth strategy: How the health system is building the hospital of the future
We mined Mayo Clinic’s investments and partnerships to discern the company's strategic priorities.
Genomics
What pharma and CRO leaders need to know about genomic profiling
We outline the market outlook for genomic profiling in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
DNAnexus hits $600M valuation for its cloud-based biomedical data analysis software. DNAnexus competitors include Seven Bridges, BC Platforms, and Lifebit.
This news comes on the heels of its Series I round. The funding will help DNAnexus support product development and international growth. Here are the top-line bullets you need to know.
LabCorp Acquires Cancer Genomics And Liquid Biopsy Company Personal Genome Diagnostics (PGDx) For $450M — A 20.5x Price/Revenue Valuation Multiple
With the acquisition, LabCorp plans to enhance its liquid biopsy and NGS-based genomic profiling capabilities. Here are the top-line bullets you need to know.
Global Genomic Data Platform For Drug Discovery Lifebit Raises $60M In Series B Led By Tiger Global
Lifebit's total funding now stands at $70.5M. Here are the top-line bullets you need to know.
State Of Healthcare Q2’21 Report: Investment & Sector Trends To Watch
Our State Of Healthcare report features data-driven insights from our emerging tech insights platform. We take a look at global healthcare investment trends in key verticals, top deals, active investors, and more.
What The 23andMe SPAC Means For The Future Of Omics
One of the pioneers of consumer genomics, 23andMe is going public via a merger with Richard Branson’s special purpose acquisition corporation (SPAC).
What Are mRNA Therapies, And How Are They Used For Vaccines?
As clinical trials ramp up, we dig into how mRNA therapies help the body combat infections, genetic diseases, and even cancer.
This DNA-Based Tech Could Transform How We Diagnose And Treat Disease
Recent FDA approvals have spurred interest in cell-free DNA tech, which are seeing increased attention and funding. Here's how the tech could improve and accelerate disease diagnostics.
State Of Healthcare Report: Investment & Sector Trends To Watch
Our healthcare report provides a data-driven look at global healthcare technology investment trends, top deals, active investors, and corporate activity.
Unbundling LabCorp: How Traditional Lab Testing Is Being Disrupted
From basic testing to clinical trials, here’s how LabCorp is being unbundled.
Can Applying AI To Genomics Improve Healthcare?
From drug discovery to precision medicine, AI is transforming the way scientists use genomic data.
Genomics Business Model Spotlight: Helix
Business Model Analysis
Helix is enabling healthcare providers to integrate genomics data into clinical care. We analyze the company's funding, business model, customer acquisition strategy, market size, and competitors.
Where Smart Money VCs Are Placing Bets In Genomics
Since 2017, healthcare Smart Money investors have participated in genomics deals worth over $6.5B in total, driving applications in gene sequencing, diagnostics, precision medicine, and more.
Genomics Funding Is On Track To Break Records As The Sector Matures
Global funding to private genomics companies has experienced fast, consistent growth since 2013. Recently, this trend has been driven by funding activity outside the US.